Literature DB >> 8709060

Risk factor control five years after coronary bypass grafting.

J S Skinner1, M Farrer, C J Albers, P C Adams.   

Abstract

The prevalence of three major coronary risk factors, hyperlipidaemia, hypertension and cigarette smoking, and the change in lipid fractions were assessed five years after coronary bypass surgery and compared to pre-operation in 353 consecutive patients undergoing elective first time surgery at a single centre. Five years after surgery 309 patients were alive without further cardiac surgery, questionnaire follow-up was available in 291 (94%). Lipid profile measurements were made in 255 (83%) of these five-year survivors and 100 (34%) had a history of hypertension. Five years after surgery, 146 (50%) of the 291 patients thought they had high cholesterol, of whom 92 (63%) were following a diet, 36 (25%) were also taking lipid-lowering drugs and 18 (12%) were taking no measures; 141 (48%) of them did not think they had high cholesterol, and four (2%) did not know. There had been a favourable change in all lipid fractions compared with pre-operation, including total serum cholesterol, particularly in patients taking lipid-lowering drugs. However, total serum cholesterol was above 5.2 mmol/l in 203 (80%) patients and low-density lipoprotein (LDL) cholesterol was above 3.4 mmol/l in 180 (71%). Only 30% of patients taking lipid-lowering drugs had an LDL cholesterol of 3.4 mmol/l or less. Blood pressure was recorded in 257 (83%) of the 309 five-year survivors: 82 (28%) were taking antihypertensive medication; 32 (12%) and 87 (34%) patients had a diastolic blood pressure above 95 mmHg and 90 mmHg, respectively, and 49 (19%) had a systolic blood pressure above 160 mmHg. There were 22 (9%) regular cigarette smokers. Corroboration of non-smoking with exhaled carbon monoxide measurements confirmed an accurate history of non-smoking in nearly all patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709060      PMCID: PMC5401540     

Source DB:  PubMed          Journal:  J R Coll Physicians Lond        ISSN: 0035-8819


  16 in total

Review 1.  Recent studies on the effects of beta blockers on blood lipid levels.

Authors:  W C Roberts
Journal:  Am Heart J       Date:  1989-03       Impact factor: 4.749

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  Relation of saphenous vein graft obstruction to serum cholesterol levels.

Authors:  H Daida; H Yokoi; H Miyano; H Mokuno; H Satoh; T E Kottke; Y Hosoda; H Yamaguchi
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

4.  The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

Authors:  L Campeau; M Enjalbert; J Lespérance; M G Bourassa; P Kwiterovich; S Wacholder; A Sniderman
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

5.  Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up.

Authors:  L Cashin-Hemphill; W J Mack; J M Pogoda; M E Sanmarco; S P Azen; D H Blankenhorn
Journal:  JAMA       Date:  1990-12-19       Impact factor: 56.272

6.  Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators.

Authors:  J B Cavender; W J Rogers; L D Fisher; B J Gersh; C J Coggin; W O Myers
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

Review 7.  Long-term results of coronary bypass surgery. Analysis of 1698 patients followed 15 to 20 years.

Authors:  G M Lawrie; G C Morris; N Earle
Journal:  Ann Surg       Date:  1991-05       Impact factor: 12.969

8.  Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery.

Authors:  L R Smith; F E Harrell; J S Rankin; R M Califf; D B Pryor; L H Muhlbaier; K L Lee; D B Mark; R H Jones; H N Oldham
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

9.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors:  D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal:  JAMA       Date:  1987-06-19       Impact factor: 56.272

10.  Risk factors among patients undergoing repeat aorta-coronary bypass procedures.

Authors:  M H Fox; H W Gruchow; J J Barboriak; A J Anderson; R G Hoffmann; R J Flemma; J F King
Journal:  J Thorac Cardiovasc Surg       Date:  1987-01       Impact factor: 5.209

View more
  2 in total

1.  Quality improvement programme for cardiovascular disease risk factor recording in primary care.

Authors:  E Ketola; R Sipilä; M Mäkelä; M Klockars
Journal:  Qual Health Care       Date:  2000-09

Review 2.  Advances in diabetes for the millennium: diabetes and cholesterol.

Authors:  Marc Rendell
Journal:  MedGenMed       Date:  2004-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.